AT1 logo

Atomo Diagnostics Limited Stock Price

ASX:AT1 Community·AU$23.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AT1 Share Price Performance

AU$0.029
0.01 (38.10%)
AU$0.029
0.01 (38.10%)
Price AU$0.029

AT1 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

Atomo Diagnostics Limited Key Details

AU$3.8m

Revenue

AU$2.0m

Cost of Revenue

AU$1.8m

Gross Profit

AU$6.8m

Other Expenses

-AU$5.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0061
47.28%
-131.08%
0%
View Full Analysis

About AT1

Founded
2010
Employees
n/a
CEO
John Kelly
WebsiteView website
atomodiagnostics.com

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Recent AT1 News & Updates

Recent updates

No updates